← Leaderboards
Mariano A. Garcia-Blanco
Duke University
$18,264,160
Attributed
$26,983,323
Total exposure
25
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,325,995 · 26
By mechanism
R01$16,823,309 · 7
P01$15,910,674 · 8
T32$2,169,113 · 2
R33$1,615,589 · 1
S10$571,574 · 2
R21$570,598 · 2
Top collaborators
- Alexander Bukreyev17 shared
- Daniel A Engel11 shared
- George Dimopoulos Dimopoulos6 shared
- Timothy A Haystead5 shared
- Norman H Lee5 shared
- Carlos A Sariol1 shared
- Judith A Woodfolk1 shared
Most similar at Duke University
Same institution · by research overlap
- Donita C Brady$4,868,613
- Michael Rod Zalutsky$18,420,913
- Arthur W Baker$942,317
- Bruce Rogers$812,397
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularLeadProgramsVirusRna SplicingBaseRna InterferenceProtein IsoformsAlternative SplicingGene ExpressionInfectionVirus DiseasesRegulationProteinsCollaborationsEventGenesDengue VirusSmall MoleculeTranscription FactorDengueTechnologyIntegration Host Factors
Grant awards (77)
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,295,613
P01 · FY2025 · AI
Medical Scientist Training Program$817,631
T32 · FY2025 · GM · contact PI
Core B: Biosafety Level 4 Core$562,319
P01 · FY2025 · AI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$412,527
P01 · FY2025 · AI
Core C: Proteogenomics Core$351,156
P01 · FY2025 · AI
Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease$350,249
P01 · FY2025 · AI
Core D: Bioinformatics and Modeling Core$125,279
P01 · FY2025 · AI
Core A: Administrative Core$65,709
P01 · FY2025 · AI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,046,958
P01 · FY2024 · AI
Medical Scientist Training Program$654,840
T32 · FY2024 · GM · contact PI
Core D: Bioinformatics and Modeling Core$470,698
P01 · FY2024 · AI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$358,578
P01 · FY2024 · AI
Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease$351,452
P01 · FY2024 · AI
Core B: Biosafety Level 4 Core$215,675
P01 · FY2024 · AI
Core C: Proteogenomics Core$165,687
P01 · FY2024 · AI
Core A: Administrative Core$73,694
P01 · FY2024 · AI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,213,113
P01 · FY2023 · AI
Medical Scientist Training Program$696,642
T32 · FY2023 · GM · contact PI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$345,353
P01 · FY2023 · AI · contact PI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,528,313
P01 · FY2022 · AI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$361,187
P01 · FY2022 · AI · contact PI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,258,675
P01 · FY2021 · AI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$358,439
P01 · FY2021 · AI · contact PI
Consequences and mechanism of aberrant splicing in African American prostate cancer disparities$357,354
R01 · FY2021 · CA
Consequences and mechanism of aberrant splicing in African American prostate cancer disparities$357,354
R01 · FY2020 · CA
Consequences and mechanism of aberrant splicing in African American prostate cancer disparities$349,273
R01 · FY2019 · CA
Consequences and mechanism of aberrant splicing in African American prostate cancer disparities$362,798
R01 · FY2018 · CA
Consequences and mechanism of aberrant splicing in African American prostate cancer disparities$376,409
R01 · FY2017 · CA
Targeting dengue in the mosquito with small molecules$1,177,188
R01 · FY2016 · AI
Targeting dengue in the mosquito with small molecules$830,881
R01 · FY2015 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$826,847
R01 · FY2014 · AI
Targeting dengue in the mosquito with small molecules$742,309
R01 · FY2014 · AI
Targeting dengue in the mosquito with small molecules$58,237
R01 · FY2014 · AI
Fourth Pan American Dengue Research Network Meeting$5,000
R13 · FY2014 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$764,373
R01 · FY2013 · AI · contact PI
Targeting dengue in the mosquito with small molecules$723,643
R01 · FY2013 · AI
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors$295,150
R01 · FY2013 · CA · contact PI
Targeting host 3'-5' exonucleases required for flaviviral infection$233,412
U54 · FY2013 · AI · contact PI
Discovery and development of broad spectrum anti-flaviviral drugs$835,261
R01 · FY2012 · AI · contact PI
Targeting dengue in the mosquito with small molecules$809,831
R01 · FY2012 · AI
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors$313,989
R01 · FY2012 · CA · contact PI
Targeting host 3'-5' exonucleases required for flaviviral infection$169,082
U54 · FY2012 · AI · contact PI
Discovery and development of broad spectrum anti-flaviviral drugs$844,425
R01 · FY2011 · AI · contact PI
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors$313,989
R01 · FY2011 · CA · contact PI
IsoCyte Laser Scanning Plate Cytometer for High-throughput, High-content Assays$294,975
S10 · FY2011 · RR · contact PI
Discovery and development of broad spectrum anti-flaviviral drugs$869,118
R01 · FY2010 · AI · contact PI
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors$323,700
R01 · FY2010 · CA · contact PI
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors$323,700
R01 · FY2009 · CA · contact PI
NUCLEIC ACID BIOLOGY$42,455
P30 · FY2009 · CA · contact PI
Regulation of Alternative Splicing of FGFR2 pre-mRNA$303,721
R01 · FY2008 · GM · contact PI
Integrated instrument system for maintenance and delivery of RNAi libraries$276,599
S10 · FY2008 · RR · contact PI
RNA-Protein Interactions in Flavivirus Infection$191,295
R21 · FY2008 · AI · contact PI
RNA-Protein Interactions in Flavivirus Infection (Dengue Virus)$100,228
U54 · FY2008 · AI · contact PI
NUCLEIC ACID BIOLOGY$29,322
P30 · FY2008 · CA · contact PI
Connections between mRNA elongation and splicing$355,985
R01 · FY2007 · GM · contact PI
Regulation of Alternative Splicing of FGFR2 pre-mRNA$303,721
R01 · FY2007 · GM · contact PI
RNA-Protein Interactions in Flavivirus Infection$234,000
R21 · FY2007 · AI · contact PI
NUCLEIC ACID BIOLOGY$28,927
P30 · FY2007 · CA · contact PI
Imaging Alternative Splicing During Tumor Progression$503,342
R33 · FY2006 · CA · contact PI
Connections between mRNA elongation and splicing$356,168
R01 · FY2006 · GM · contact PI
Regulation of Alternative Splicing of FGFR2 pre-mRNA$312,792
R01 · FY2006 · GM · contact PI
NUCLEIC ACID BIOLOGY$28,543
P30 · FY2006 · CA · contact PI
Imaging Alternative Splicing During Tumor Progression$518,873
R33 · FY2005 · CA
Connections between mRNA elongation and splicing$354,352
R01 · FY2005 · GM
Regulation of Alternative Splicing of FGFR2 pre-mRNA$311,334
R01 · FY2005 · GM
NUCLEIC ACID BIOLOGY$28,169
P30 · FY2005 · CA
Imaging Alternative Splicing During Tumor Progression$593,374
R33 · FY2004 · CA
Connections between mRNA elongation and splicing$344,268
R01 · FY2004 · GM
Regulation of Alternative Splicing of FGF-R2 pre-mRNA$290,693
R01 · FY2004 · GM
CELLULAR COACTIVATORS OF THE HIV 1 PROMOTER$308,000
R01 · FY2003 · AI
Regulation of Alternative Splicing of FGF-R2 pre-mRNA$289,457
R01 · FY2003 · GM
CELLULAR COACTIVATORS OF THE HIV 1 PROMOTER$308,000
R01 · FY2002 · AI
Regulation of Alternative Splicing of FGF-R2 pre-mRNA$242,080
R01 · FY2002 · GM
Imaging Alternative Splicing During Tumor Progression$145,303
R21 · FY2002 · CA
CELLULAR COACTIVATORS OF THE HIV 1 PROMOTER$308,000
R01 · FY2001 · AI
Regulation of Alternative Splicing of FGF-R2 pre-mRNA$242,080
R01 · FY2001 · GM
CELLULAR COACTIVATORS OF THE HIV 1 PROMOTER$336,829
R01 · FY2000 · AI